Skip to main content

Primary Histiocytic Disorders of the Lung

  • Chapter
  • First Online:
Orphan Lung Diseases

Abstract

The primary histiocytic disorders of the lung, pulmonary Langerhans cell histiocytosis, Erdheim Chester Disease, and Rosai-Dorfman-Destombes Disease are rare inflammatory neoplasms that have recently been found to harbor growth and survival-promoting mutations in key signaling pathways of myeloid cells. These discoveries have revolutionized our understanding of disease pathogenesis in these disorders and revealed promising new molecular targets for therapy. There are a number of secondary histiocytic disorders associated with reactive accumulation of histiocytes due to infections (e.g. tuberculosis), storage disorders (e.g. Gaucher, Niemann Pick Disease, crystal storing histiocytosis), or various other conditions (bronchiolar obstruction, nonspecific interstitial pneumonia, and Whipple disease) that will be not be covered here. Malignant histiocytic conditions (e.g. histiocytic sarcoma, primary Langerhans sarcoma, follicular dendritic cell sarcoma, interdigitating dendritic cell sarcoma) are also beyond the scope of this review. We will instead focus on these three fascinating ‘benign metastasizing’ conditions of adults, that have recently been discovered to share common genetic and pathogenic origins.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Goyal G, Heaney ML, Collin M, Cohen-Aubart F, Vaglio A, Durham BH, et al. Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era. Blood. 2020;135(22):1929–45. https://doi.org/10.1182/blood.2019003507.

    Article  CAS  PubMed  Google Scholar 

  2. Abla O, Jacobsen E, Picarsic J, Krenova Z, Jaffe R, Emile JF, et al. Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease. Blood. 2018;131(26):2877–90. https://doi.org/10.1182/blood-2018-03-839753.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Allen CE, Merad M, McClain KL. Langerhans-cell histiocytosis. N Engl J Med. 2018;379(9):856–68. https://doi.org/10.1056/NEJMra1607548.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Goyal G, Young JR, Koster MJ, Tobin WO, Vassallo R, Ryu JH, et al. The Mayo Clinic Histiocytosis Working Group consensus statement for the diagnosis and evaluation of adult patients with histiocytic neoplasms: Erdheim-Chester disease, Langerhans cell histiocytosis, and Rosai-Dorfman disease. Mayo Clin Proc. 2019;94(10):2054–71. https://doi.org/10.1016/j.mayocp.2019.02.023.

    Article  PubMed  Google Scholar 

  5. Durham BH, Lopez Rodrigo E, Picarsic J, Abramson D, Rotemberg V, De Munck S, et al. Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms. Nat Med. 2019;25(12):1839–42. https://doi.org/10.1038/s41591-019-0653-6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. DeMartino E, Go RS, Vassallo R. Langerhans cell histiocytosis and other histiocytic diseases of the lung. Clin Chest Med. 2016;37(3):421–30. https://doi.org/10.1016/j.ccm.2016.04.005.

    Article  PubMed  Google Scholar 

  7. Rao RN, Moran CA, Suster S. Histiocytic disorders of the lung. Adv Anat Pathol. 2010;17:12–22. https://doi.org/10.1097/PAP.0b013e3181c6a524.

    Article  Google Scholar 

  8. Hogstad B, Berres ML, Chakraborty R, Tang J, Bigenwald C, Serasinghe M, et al. RAF/MEK/extracellular signal-related kinase pathway suppresses dendritic cell migration and traps dendritic cells in Langerhans cell histiocytosis lesions. J Exp Med. 2018;215(1):319–36. https://doi.org/10.1084/jem.20161881.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Zhang W, Liu HT. MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res. 2002;12(1):9–18. https://doi.org/10.1038/sj.cr.7290105.

    Article  CAS  PubMed  Google Scholar 

  10. Munoz J, Janku F, Cohen PR, Kurzrock R. Erdheim-Chester disease: characteristics and management. Mayo Clin Proc. 2014;89(7):985–96. https://doi.org/10.1016/j.mayocp.2014.01.023.

    Article  CAS  PubMed  Google Scholar 

  11. Gallego CT, Bueno J, Cruces E, Stelow EB, Mancheno N, Flors L. Pulmonary histiocytosis: beyond Langerhans cell histiocytosis related to smoking. Radiologia. 2019;61(3):215–24. https://doi.org/10.1016/j.rx.2018.11.003.

    Article  PubMed  Google Scholar 

  12. Hoeffel G, Wang Y, Greter M, See P, Teo P, Malleret B, et al. Adult Langerhans cells derive predominantly from embryonic fetal liver monocytes with a minor contribution of yolk sac-derived macrophages. J Exp Med. 2012;209(6):1167–81. https://doi.org/10.1084/jem.20120340.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Hutter C, Kauer M, Simonitsch-Klupp I, Jug G, Schwentner R, Leitner J, et al. Notch is active in Langerhans cell histiocytosis and confers pathognomonic features on dendritic cells. Blood. 2012;120(26):5199–208. https://doi.org/10.1182/blood-2012-02-410241.

    Article  CAS  PubMed  Google Scholar 

  14. Allen CE, Li L, Peters TL, Leung HC, Yu A, Man TK, et al. Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells. J Immunol. 2010;184(8):4557–67. https://doi.org/10.4049/jimmunol.0902336.

    Article  CAS  PubMed  Google Scholar 

  15. Annels NE, Da Costa CE, Prins FA, Willemze A, Hogendoorn PC, Egeler RM. Aberrant chemokine receptor expression and chemokine production by Langerhans cells underlies the pathogenesis of Langerhans cell histiocytosis. J Exp Med. 2003;197(10):1385–90. https://doi.org/10.1084/jem.20030137.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Xiao Y, van Halteren AGS, Lei X, Borst J, Steenwijk E, de Wit T, et al. Bone marrow-derived myeloid progenitors as driver mutation carriers in high- and low-risk Langerhans cell histiocytosis. Blood. 2020;136(19):2188–99. https://doi.org/10.1182/blood.2020005209.

    Article  CAS  PubMed  Google Scholar 

  17. Satpathy AT, Brown RA, Gomulia E, Briseno CG, Mumbach MR, Pan Z, et al. Expression of the transcription factor ZBTB46 distinguishes human histiocytic disorders of classical dendritic cell origin. Mod Pathol. 2018;31(9):1479–86. https://doi.org/10.1038/s41379-018-0052-4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Berres ML, Merad M, Allen CE. Progress in understanding the pathogenesis of Langerhans cell histiocytosis: back to Histiocytosis X? Br J Haematol. 2015;169(1):3–13. https://doi.org/10.1111/bjh.13247.

    Article  PubMed  Google Scholar 

  19. Yamaguchi M, Shiota T, Kobashi Y. Erdheim-Chester disease presenting with pneumothorax. Respiration. 2011;82(6):552–6. https://doi.org/10.1159/000329872.

    Article  PubMed  Google Scholar 

  20. R. Nagarjun Rao M, FRCPath. Histiocytic disorders of the lung. Adv Anat Pathol. 2010;17(1):12–22.

    Article  Google Scholar 

  21. Cives M, Simone V, Rizzo FM, Dicuonzo F, Cristallo Lacalamita M, Ingravallo G, et al. Erdheim-Chester disease: a systematic review. Crit Rev Oncol Hematol. 2015;95(1):1–11. https://doi.org/10.1016/j.critrevonc.2015.02.004.

    Article  PubMed  Google Scholar 

  22. Go RJ, Baiocchi R, Buhtoiarov I, Butler EB, Campbell PK, Coulter DW, Diamond E, Flagg A, Goodman AM, Goyal G, Gratzinger D, Hendrie PC, Higman M, Hogarty MD, Janki F, Karmali R, Morgan D, Raldow AC, Stefanovic A, Tantravahi SK, Walkovich K, Zhang L. National Comprehensive Cancer Network NCCN Clinical practice guidelines (NCCN guidelines); 2021.

    Google Scholar 

  23. Arnaud L, Pierre I, Beigelman-Aubry C, Capron F, Brun AL, Rigolet A, et al. Pulmonary involvement in Erdheim-Chester disease: a single-center study of thirty-four patients and a review of the literature. Arthritis Rheum. 2010;62(11):3504–12. https://doi.org/10.1002/art.27672.

    Article  PubMed  Google Scholar 

  24. Diamond EL, Durham BH, Ulaner GA, Drill E, Buthorn J, Ki M, et al. Efficacy of MEK inhibition in patients with histiocytic neoplasms. Nature. 2019;567(7749):521–4. https://doi.org/10.1038/s41586-019-1012-y.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Picarsic J, Jaffe R. Pathology of histiocytic disorders and neoplasms and related disorders. Cham: Springer International Publishing; 2017. p. 3–50.

    Google Scholar 

  26. Garcia-Gomez FJ, Acevedo-Banez I, Martinez-Castillo R, Tirado-Hospital JL, Cuenca-Cuenca JI, Pachon-Garrudo VM, et al. The role of 18FDG, 18FDOPA PET/CT and 99mTc bone scintigraphy imaging in Erdheim-Chester disease. Eur J Radiol. 2015;84(8):1586–92. https://doi.org/10.1016/j.ejrad.2015.04.022.

    Article  CAS  PubMed  Google Scholar 

  27. Mazor RD, Manevich-Mazor M, Shoenfeld Y. Erdheim-Chester disease: a comprehensive review of the literature. Orphanet J Rare Dis. 2013;8:137. https://doi.org/10.1186/1750-1172-8-137.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Picarsic J, Pysher T, Zhou H, Fluchel M, Pettit T, Whitehead M, et al. BRAF V600E mutation in Juvenile Xanthogranuloma family neoplasms of the central nervous system (CNS-JXG): a revised diagnostic algorithm to include pediatric Erdheim-Chester disease. Acta Neuropathol Commun. 2019;7(1):168. https://doi.org/10.1186/s40478-019-0811-6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Techavichit P, Sosothikul D, Chaichana T, Teerapakpinyo C, Thorner PS, Shuangshoti S. BRAF V600E mutation in pediatric intracranial and cranial Juvenile Xanthogranuloma. Hum Pathol. 2017;69:118–22. https://doi.org/10.1016/j.humpath.2017.04.026.

    Article  CAS  PubMed  Google Scholar 

  30. Lim KPH, Milne P, Poidinger M, Duan K, Lin H, McGovern N, et al. Circulating CD1c+ myeloid dendritic cells are potential precursors to LCH lesion CD1a+CD207+ cells. Blood Adv. 2020;4(1):87–99. https://doi.org/10.1182/bloodadvances.2019000488.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Cangi MG, Biavasco R, Cavalli G, Grassini G, Dal-Cin E, Campochiaro C, et al. BRAFV600E-mutation is invariably present and associated to oncogene-induced senescence in Erdheim-Chester disease. Ann Rheum Dis. 2015;74(8):1596–602. https://doi.org/10.1136/annrheumdis-2013-204924.

    Article  CAS  PubMed  Google Scholar 

  32. Gianfreda D, Nicastro M, Galetti M, Alberici F, Corradi D, Becchi G, et al. Sirolimus plus prednisone for Erdheim-Chester disease: an open-label trial. Blood. 2015;126(10):1163–71. https://doi.org/10.1182/blood-2015-01-620377.

    Article  CAS  PubMed  Google Scholar 

  33. Pegoraro F, Papo M, Maniscalco V, Charlotte F, Haroche J, Vaglio A. Erdheim-Chester disease: a rapidly evolving disease model. Leukemia. 2020;34(11):2840–57. https://doi.org/10.1038/s41375-020-0944-4.

    Article  CAS  PubMed  Google Scholar 

  34. Moyon Q, Boussouar S, Maksud P, Emile JF, Charlotte F, Aladjidi N, et al. Lung involvement in Destombes-Rosai-Dorfman disease: clinical and radiological features and response to the MEK inhibitor cobimetinib. Chest. 2020;157(2):323–33. https://doi.org/10.1016/j.chest.2019.09.036.

    Article  CAS  PubMed  Google Scholar 

  35. Garces S, Medeiros LJ, Patel KP, Li S, Pina-Oviedo S, Li J, et al. Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai-Dorfman disease. Mod Pathol. 2017;30(10):1367–77. https://doi.org/10.1038/modpathol.2017.55.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Garces S, Yin CC, Patel KP, Khoury JD, Manning JT Jr, Li S, et al. Focal Rosai-Dorfman disease coexisting with lymphoma in the same anatomic site: a localized histiocytic proliferation associated with MAPK/ERK pathway activation. Mod Pathol. 2019;32(1):16–26. https://doi.org/10.1038/s41379-018-0152-1.

    Article  CAS  PubMed  Google Scholar 

  37. Baraban E, Sadigh S, Rosenbaum J, Van Arnam J, Bogusz AM, Mehr C, et al. Cyclin D1 expression and novel mutational findings in Rosai-Dorfman disease. Br J Haematol. 2019;186(6):837–44. https://doi.org/10.1111/bjh.16006.

    Article  CAS  PubMed  Google Scholar 

  38. Mastropolo R, Close A, Allen SW, McClain KL, Maurer S, Picarsic J. BRAF-V600E-mutated Rosai-Dorfman-Destombes disease and Langerhans cell histiocytosis with response to BRAF inhibitor. Blood Adv. 2019;3(12):1848–53. https://doi.org/10.1182/bloodadvances.2019000093.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Ravindran A, Goyal G, Go RS, Rech KL, Mayo Clinic Histiocytosis Working Group. Rosai-Dorfman disease displays a unique monocyte-macrophage phenotype characterized by expression of OCT2. Am J Surg Pathol. 2021;45(1):35–44. https://doi.org/10.1097/PAS.0000000000001617.

    Article  PubMed  Google Scholar 

  40. Cartin-Ceba R, Golbin JM, Yi ES, Prakash UB, Vassallo R. Intrathoracic manifestations of Rosai-Dorfman disease. Respir Med. 2010;104(9):1344–9. https://doi.org/10.1016/j.rmed.2010.03.024.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We thank Ava Borchers for assistance with Fig. 16.1 graphics.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Melanie Dalton or Francis X. McCormack .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Dalton, M., Meyer, C., Picarsic, J., Borchers, M., McCormack, F.X. (2023). Primary Histiocytic Disorders of the Lung. In: Cottin, V., Richeldi, L., Brown, K., McCormack, F.X. (eds) Orphan Lung Diseases. Springer, Cham. https://doi.org/10.1007/978-3-031-12950-6_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-12950-6_16

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-12949-0

  • Online ISBN: 978-3-031-12950-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics